{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:50:58Z","timestamp":1785192658289,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005003","name":"Baskent \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.breast.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T23:51:31Z","timestamp":1538178691000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy"],"prefix":"10.1016","volume":"42","author":[{"given":"Cem","family":"Onal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan Cem","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna Akkus","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2018.09.006_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2018.09.006_bib2","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/cncr.21778","article-title":"Metastatic patterns in adenocarcinoma","volume":"106","author":"Hess","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2018.09.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tranon.2016.10.004","article-title":"Up-regulation of RFC3 promotes triple negative breast cancer metastasis and is associated with poor prognosis via EMT","volume":"10","author":"He","year":"2017","journal-title":"Transl Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib4","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/annonc\/mdn424","article-title":"Prognostic factors in 1,038 women with metastatic breast cancer","volume":"19","author":"Largillier","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/01.sla.0000246847.02058.1b","article-title":"Is liver resection justified for patients with hepatic metastases from breast cancer?","volume":"244","author":"Adam","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2018.09.006_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.seminoncol.2014.09.016","article-title":"The role of surgery and ablative radiotherapy in oligometastatic breast cancer","volume":"41","author":"Salama","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib8","first-page":"7005","article-title":"Stereotactic body radiation therapy in primary and metastatic liver disease","volume":"37","author":"Caivano","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.breast.2018.09.006_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.prro.2015.10.011","article-title":"Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases","volume":"6","author":"Goodman","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semradonc.2011.05.003","article-title":"Hepatic radiation toxicity: avoidance and amelioration","volume":"21","author":"Guha","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2012.12.021","article-title":"Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial","volume":"86","author":"Scorsetti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2018.09.006_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2017.02.004","article-title":"Stereotactic body radiotherapy for liver metastases","volume":"27","author":"Goodman","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ijrobp.2007.08.058","article-title":"Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors","volume":"70","author":"Mendez Romero","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2018.09.006_bib15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/02841860600904854","article-title":"Phase II study on stereotactic body radiotherapy of colorectal metastases","volume":"45","author":"Hoyer","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib16","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1245\/s10434-010-0931-5","article-title":"Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors","volume":"17","author":"Hoffmann","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.surg.2011.12.017","article-title":"Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome","volume":"151","author":"Abbott","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.breast.2018.09.006_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.meddos.2010.08.002","article-title":"Helical tomotherapy-based STAT stereotactic body radiation therapy: dosimetric evaluation for a real-time SBRT treatment planning and delivery program","volume":"35","author":"Dunlap","year":"2010","journal-title":"Med Dosim"},{"key":"10.1016\/j.breast.2018.09.006_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmp.2015.09.009","article-title":"Multicentre treatment planning inter-comparison in a national context: the liver stereotactic ablative radiotherapy case","volume":"32","author":"Esposito","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.breast.2018.09.006_bib20","first-page":"349","article-title":"Stereotactic robotic body radiotherapy for patients with unresectable hepatic oligorecurrence","volume":"16","author":"Berkovic","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.breast.2018.09.006_bib21","doi-asserted-by":"crossref","first-page":"122s","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving Considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.breast.2018.09.006_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000012098","article-title":"A\u00a0retrospective study of first indicators of breast cancer recurrence","volume":"58","author":"Pivot","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.breast.2018.09.006_bib23","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","article-title":"Review and uses of stereotactic body radiation therapy for oligometastases","volume":"17","author":"Alongi","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.breast.2018.09.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-190707000-00001","article-title":"The results of radical operations for the cure of carcinoma of the breast","volume":"46","author":"Halsted","year":"1907","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2018.09.006_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0002-9610(02)01204-7","article-title":"An attempt to clarify indications for hepatectomy for liver metastases from breast cancer","volume":"185","author":"Elias","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.breast.2018.09.006_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ejso.2013.09.021","article-title":"Liver metastases from breast cancer: surgical resection or not? A case-matched control study in highly selected patients","volume":"39","author":"Mariani","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib27","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/j.ejrad.2013.08.046","article-title":"Transarterial chemoembolisation (TACE) with gemcitabine: phase II study in patients with liver metastases of breast cancer","volume":"82","author":"Eichler","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.breast.2018.09.006_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00270-008-9384-7","article-title":"CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer","volume":"32","author":"Jakobs","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.breast.2018.09.006_bib29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.hpb.2016.05.014","article-title":"The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis","volume":"18","author":"Margonis","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.breast.2018.09.006_bib30","doi-asserted-by":"crossref","first-page":"W66","DOI":"10.2214\/AJR.09.3836","article-title":"Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer","volume":"196","author":"Vogl","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.breast.2018.09.006_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11547-013-0354-z","article-title":"Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease","volume":"119","author":"Veltri","year":"2014","journal-title":"Radiol Med"},{"key":"10.1016\/j.breast.2018.09.006_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jvir.2017.09.027","article-title":"Stereotactic radiofrequency ablation for breast cancer liver metastases","volume":"29","author":"Bale","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.breast.2018.09.006_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-018-4714-1","article-title":"Long-term survival and cure model following liver resection for breast cancer metastases","volume":"170","author":"Ruiz","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2018.09.006_bib34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00432-013-1440-2","article-title":"Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature","volume":"139","author":"Dittmar","year":"2013","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib35","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3748\/wjg.v11.i24.3782","article-title":"Treatment for liver metastases from breast cancer: results and prognostic factors","volume":"11","author":"Li","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.breast.2018.09.006_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1148\/radiol.2533081968","article-title":"Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation\u2013intermediate and long-term survival rates","volume":"253","author":"Meloni","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2018.09.006_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1245\/ASO.2006.05.039","article-title":"Survival after hepatic resection for colorectal metastases: a 10-year experience","volume":"13","author":"Wei","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2018.02.024","article-title":"Surgical resection versus systemic therapy for breast cancer liver metastases: results of a European case matched comparison","volume":"95","author":"Ruiz","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2018.09.006_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.breast.2017.09.001","article-title":"Transarterial chemoembolisation for breast cancer with liver metastasis: a systematic review","volume":"36","author":"Wang","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.breast.2018.09.006_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiol.2262012198","article-title":"Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study","volume":"226","author":"Livraghi","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2018.09.006_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00330-012-2662-4","article-title":"Thermal ablation therapies in patients with breast cancer liver metastases: a review","volume":"23","author":"Vogl","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.breast.2018.09.006_bib42","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3748\/wjg.15.2651","article-title":"Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients","volume":"15","author":"Kong","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.breast.2018.09.006_bib43","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.breast.2018.09.006_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study","volume":"45","author":"Mendez Romero","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib46","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","article-title":"Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies","volume":"78","author":"Goodman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2018.09.006_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-014-1833-x","article-title":"Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.rpor.2016.10.003","article-title":"Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy","volume":"22","author":"Mendez Romero","year":"2017","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.breast.2018.09.006_bib50","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2006.10.025","article-title":"Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases","volume":"67","author":"Katz","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2018.09.006_bib51","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/02841860600904821","article-title":"Stereotactic radiotherapy of primary liver cancer and hepatic metastases","volume":"45","author":"Wulf","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cncr.23209","article-title":"A\u00a0prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions","volume":"112","author":"Milano","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2018.09.006_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10549-008-0157-4","article-title":"Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy","volume":"115","author":"Milano","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2018.09.006_bib54","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1002\/cncr.29681","article-title":"Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy","volume":"121","author":"Bishop","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2018.09.006_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/0284186X.2011.558522","article-title":"Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: feasibility and clinical preliminary results","volume":"50","author":"Scorsetti","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2016.04.020","article-title":"Motion management during SBRT for oligometastatic cancer: results of a prospective phase II trial","volume":"119","author":"Van den Begin","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib57","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ijrobp.2007.12.023","article-title":"Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver","volume":"70","author":"Heinzerling","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2018.09.006_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0958-3947(02)00136-X","article-title":"Patient training in respiratory-gated radiotherapy","volume":"28","author":"Kini","year":"2003","journal-title":"Med Dosim"},{"key":"10.1016\/j.breast.2018.09.006_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.radonc.2011.01.015","article-title":"Geometric accuracy of a novel gimbals based radiation therapy tumor tracking system","volume":"98","author":"Depuydt","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib60","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.ijrobp.2005.03.072","article-title":"Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control","volume":"62","author":"Dawson","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2018.09.006_bib61","first-page":"190","article-title":"Stereotactic body radiation therapy for liver metastases","volume":"5","author":"Scorsetti","year":"2014","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2010.04.070","article-title":"Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer","volume":"78","author":"Brown","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2018.09.006_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13014-018-1049-3","article-title":"Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer","volume":"13","author":"Britschgi","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.breast.2018.09.006_bib64","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological mechanisms responsible for radiation-induced abscopal effect","volume":"39","author":"Rodriguez-Ruiz","year":"2018","journal-title":"Trends Immunol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977618302996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977618302996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:40:12Z","timestamp":1760776812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977618302996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":64,"alternative-id":["S0960977618302996"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2018.09.006","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}